A recent study suggests that the perceived benefits of microdosing psychedelics for depression may be largely due to the placebo effect. The research found that participants who believed they were taking small amounts of substances like psilocybin reported similar improvements in mood and well-being as those who actually microdosed. Notably, the study also compared these effects to a group consuming caffeine and found comparable outcomes, indicating that expectation and routine may play a significant role. The findings highlight the need for more rigorous, controlled trials to separate the pharmacological effects from psychological expectations in microdosing research. Read the full article at: https://www.wired.com/story/microdosing-for-depression-appears-to-work-about-as-well-as-drinking-coffee/